Urinary Catheters Market

Urinary Catheters Market to Reach USD 11.9 Billion by 2035. The market is driven by rising urinary disorders, aging population, and healthcare advancements

According to analysts at Vantage Market Research, the Global Urinary Catheters Market size is worth USD 6.8 Billion in 2025 and is projected to reach USD 11.9 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 5.8% from 2026 to 2035. Key trends include rising adoption of antimicrobial-coated catheters, increasing preference for intermittent catheterization, technological advancements in silicone-based products, growing home healthcare usage, expanding geriatric population, and integration of smart monitoring solutions in urinary care management.

Urinary Catheters Market Overview

The global Urinary Catheters Market is witnessing significant growth due to the increasing prevalence of urinary incontinence, bladder dysfunction, urinary retention, and chronic kidney disorders worldwide. Rising hospitalization rates, expanding geriatric population, and growing number of surgical procedures are driving demand for urinary catheterization products across hospitals, clinics, and homecare settings. Technological advancements such as antimicrobial-coated catheters, hydrophilic coatings, and silicone-based materials are improving patient comfort, reducing infection risks, and supporting long-term catheter usage.

The market is further supported by the increasing adoption of intermittent catheters, growing awareness regarding infection prevention, and expanding home healthcare services. Demand is also increasing among patients with spinal cord injuries, neurological disorders, and post-operative urinary complications. North America dominates the market owing to advanced healthcare infrastructure, high healthcare expenditure, and strong adoption of innovative urinary care products, while Asia-Pacific is expected to witness the fastest growth due to improving healthcare access, rising elderly population, and increasing investments in medical device manufacturing.

However, concerns related to catheter-associated urinary tract infections (CAUTIs), product recalls, and reimbursement limitations in certain regions may restrain market expansion. Despite these challenges, ongoing product innovation, increasing focus on patient-centric urinary management, and rising demand for minimally invasive care solutions are expected to create substantial growth opportunities through 2035.

Becton, Dickinson and Company Introduced Upgraded Antimicrobial Foley Catheter Platform

• March 2025 — Becton, Dickinson and Company introduced an upgraded antimicrobial Foley catheter platform targeting lower hospital-acquired infection exposure across acute-care settings

Key Takeaways from the Report

• North America dominated the global market in 2025 with approximately 38.4% revenue share due to advanced healthcare infrastructure, strong reimbursement coverage, and high surgical procedure volumes.
• Indwelling catheters held the largest product segment share of nearly 46.7% in 2025 owing to extensive use across hospitals, ICUs, and long-term care facilities.
• Silicone catheters accounted for around 41.2% of market revenue in 2025 because of superior biocompatibility, reduced irritation risk, and extended dwell-time performance.
• Hospitals represented the leading end-user segment with over 52.5% demand share in 2025 due to widespread catheter usage in perioperative care and inpatient monitoring.
• Urinary incontinence remained the largest indication segment, supported by rising elderly populations and increasing mobility-related urinary complications globally.

Top Players

• Becton, Dickinson and Company 
• Coloplast A/S 
• Teleflex Incorporated 
• B. Braun SE 
• Hollister Incorporated 
• Convatec Group plc 
• Cardinal Health 
• Medtronic plc 
• Cook Medical 
• Boston Scientific Corporation 

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events like the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest Announcement

• January 2025 — Coloplast A/S expanded intermittent catheter manufacturing capacity in Europe, strengthening supply continuity for home-care distribution channels and reducing regional procurement lead times.